Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the target of a large drop in short interest in July. As of July 31st, there was short interest totalling 386,700 shares, a drop of 21.5% from the July 15th total of 492,300 shares. Approximately 1.3% of the shares of the stock are short sold. Based on an average daily volume of 58,300 shares, the short-interest ratio is currently 6.6 days.
Analyst Ratings Changes
A number of research analysts have recently weighed in on BIOX shares. Roth Mkm began coverage on shares of Bioceres Crop Solutions in a research note on Tuesday, July 2nd. They set a “buy” rating and a $15.00 price objective for the company. Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Canaccord Genuity Group restated a “buy” rating and set a $17.00 target price on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Finally, Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Three investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $19.00.
Check Out Our Latest Stock Analysis on BIOX
Hedge Funds Weigh In On Bioceres Crop Solutions
Bioceres Crop Solutions Trading Up 0.2 %
Shares of BIOX traded up $0.02 during mid-day trading on Friday, reaching $10.18. The company had a trading volume of 22,714 shares, compared to its average volume of 57,506. The stock has a market cap of $639.27 million, a price-to-earnings ratio of 1,018.00 and a beta of 0.50. The firm has a fifty day simple moving average of $10.78 and a 200-day simple moving average of $11.86. Bioceres Crop Solutions has a fifty-two week low of $9.71 and a fifty-two week high of $14.05. The company has a current ratio of 1.22, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last announced its quarterly earnings results on Wednesday, May 29th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The company had revenue of $83.98 million during the quarter, compared to analyst estimates of $88.80 million. Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. On average, sell-side analysts anticipate that Bioceres Crop Solutions will post 0.35 EPS for the current fiscal year.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Investing in Construction Stocks
- MarketBeat Week in Review – 8/12 – 8/16
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.